Our demonstration in GBM specimens that expression of both FABP7 and EGFR correlated with each other at both protein and mRNA levels, and in SF763 glioma cells that EGFR activation induced nuclear translocation of FABP7, warrants further investigation of whether FABP7 is a direct downstream target of EGFR activation in GBM and which EGFR pathway FABP7 is associated with. Here, EGFR is linked to central nervous system cancer.